Teicoplanin Dosing Recommendations
For standard infections, administer a loading dose of 6 mg/kg IV every 12 hours for three doses, followed by 6 mg/kg IV once daily; for severe infections (endocarditis, septic arthritis, osteomyelitis), use 12 mg/kg IV every 12 hours for three doses, followed by 12 mg/kg IV once daily, with dosing intervals extended based on renal function. 1, 2
Loading Dose Strategy
The loading dose is critical and must be given at full dose regardless of renal function, as it depends on volume of distribution rather than clearance. 1, 2
- Standard infections: 6 mg/kg IV every 12 hours for three doses 1, 2
- Severe infections (S. aureus endocarditis, septic arthritis, osteomyelitis, bacteremia): 12 mg/kg IV every 12 hours for three doses 1, 2, 3
- In critically ill patients with expanded extracellular volume from fluid resuscitation, aggressive loading is essential to rapidly achieve therapeutic levels 1
- Failure to provide adequate loading doses leads to subtherapeutic levels regardless of renal function 1
Maintenance Dosing Based on Renal Function
After completing the loading regimen, adjust maintenance dosing according to GFR:
- GFR >50 mL/min: 6-12 mg/kg every 24 hours 1, 2
- GFR 10-50 mL/min: 6-12 mg/kg every 48 hours 1, 2
- GFR <10 mL/min: 6-12 mg/kg every 72 hours 1, 2
The dose per kilogram remains the same; only the interval changes with renal impairment. 1
Infection-Specific Dosing
Severe Infections Requiring Higher Doses (12 mg/kg)
- Endocarditis: 12 mg/kg every 12 hours for three doses, then 12 mg/kg once daily for 4-6 weeks 2, 3
- Septic arthritis: 12 mg/kg every 12 hours for three doses, then 12 mg/kg once daily for 3-4 weeks 2, 3
- Osteomyelitis: 12 mg/kg every 12 hours for three doses, then 12 mg/kg once daily for >6 weeks 2, 3
- Complicated bacteremia: 12 mg/kg every 12 hours for three to six doses, then 12 mg/kg once daily for 4-6 weeks 2
Standard Infections (6 mg/kg)
- Uncomplicated bacteremia: 6 mg/kg every 12 hours for three doses, then 6 mg/kg once daily for 2 weeks 2
- Complicated skin and soft tissue infections: 6 mg/kg every 12 hours for three doses, then 6 mg/kg once daily for 7-14 days 2
Special Populations
Hemodialysis Patients
- Loading dose: 12 mg/kg, followed by 6 mg/kg on days 2 and 3 1, 2
- Maintenance: 6 mg/kg once weekly 1, 2
CAPD Peritonitis
Continuous Renal Replacement Therapy (CVVH/CAVH)
Pediatric Patients
- Loading dose: 10 mg/kg IV every 12 hours for three doses 4
- Maintenance dose: 6-10 mg/kg IV every 24 hours (adjust intervals for renal impairment as in adults) 4
- For severe infections, consider 12 mg/kg loading doses and 10-12 mg/kg maintenance 4
Therapeutic Drug Monitoring
Routine monitoring is not required for most patients, but is mandatory in specific high-risk situations: 1, 2
- S. aureus endocarditis or septic arthritis 1, 2
- Major burns 1, 2
- Intravenous drug users 1, 2
- Rapidly changing renal function 1, 2
- Immunocompromised patients 1, 2
- Pediatric patients (due to highly variable pharmacokinetics) 4
Target Trough Concentrations
- Standard infections: ≥10 mg/L 1, 2
- Severe infections (endocarditis, septic arthritis, bacteremia): ≥20 mg/L 1, 2, 3
- Therapeutic window: 15-30 mg/L for most infections 1
- Potentially toxic levels: >60 mg/L 1, 5
Practical Considerations for Optimal Dosing
In stable adult patients with normal renal function, a 600 mg twice daily loading regimen (two doses) followed by 600 mg daily maintenance achieves therapeutic levels more frequently (68% vs 37%) without increasing toxic levels, compared to the traditional 400 mg daily dosing. 5
Common Pitfalls to Avoid
- Never reduce loading doses for renal impairment—this leads to delayed therapeutic levels 1
- Do not overlook the need for higher doses (12 mg/kg) in endocarditis and septic arthritis—lower doses result in treatment failure 1, 3
- Extend dosing intervals appropriately in renal impairment—failure to do so causes drug accumulation 1
- Monitor high-risk patients—suboptimal outcomes occur when therapeutic drug monitoring is overlooked in severe infections 1
Safety Profile
High loading doses (12 mg/kg twice daily) have an acceptable safety profile with nephrotoxicity occurring in approximately 7.9% of patients, with no increased risk compared to standard dosing when patients are appropriately monitored. 6